Get startedLog in
    Picture of Xeno Transplants logo

    XENO — Xeno Transplants Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Xeno Transplants, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    2005
    June 30th
    2006
    June 30th
    2007
    June 30th
    Period Length:9 M12 M6 M
    Source:PROSPECTUS10KSB10KSB
    Standards:
    USG
    USG
    USG
    Status:FinalFinalFinal
    Revenue
    Total Revenue000
    Selling / General / Administrative Expenses
    Total Operating Expenses0.0330.0470.128
    Operating Profit-0.033-0.047-0.128
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes-0.033-0.047-0.128
    Provision for Income Taxes
    Net Income After Taxes-0.033-0.047-0.128
    Net Income Before Extraordinary Items
    Net Income-0.033-0.047-0.128
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income-0.033-0.047-0.128
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.001-0.002-0.004
    Dividends per Share